Total Funding
81
30
Total FundingDebt Financing raised
Growth Score
-5 pts
Heat Score
-1 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
483435
Afraxis is a contract research organization focused on CNS pharmaceutical screening technologies for assessing pre-clinical therapeutics.
Douglas Downs: Acting Chief Financial Officer- Christopher Rex: Chief Scientific Officer
About the Company
Afraxis offers enhanced spine platform technology that generates a synaptic network information read-out from whole brain or other tissue preparations. They also provide drug discovery services. Their customers inquiries are addressed through phone, email, and online applications.
